| 研究报告 |
|
|
|
|
| 重组小鼠白细胞介素-33的原核表达制备及其粘膜免疫佐剂活性 |
| 冯雪军1,2,3, 龙琼1,2,3, 唐增华1,2,3, 黄惟巍1,2,3, 刘存宝1,2,3, 杨旭1,2,3, 孙文佳1,2,3, 白红妹1,2,3, 马雁冰1,2,3 |
1 中国医学科学院、北京协和医学院 医学生物学研究所 昆明 650118;
2 云南省重大传染病疫苗研发重点实验室 昆明 650118;
3. 云南省重大传染病疫苗工程技术研究中心 昆明 650118 |
|
| The Prokaryotic Expression of Recombinant Murine Interlukin (IL)-33 and Its Mucosal Immunization Affect as Adjuvant |
| FENG Xue-jun1,2,3, LONG Qiong1,2,3, TANG Zeng-hua1,2,3, HUANG Wei-wei1,2,3, LIU Cun-bao1,2,3, YANG Xu1,2,3, SUN Wen-jia1,2,3, BAI Hong-mei1,2,3, MA Yan-bing1,2,3 |
1 Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, China;
2 Yunnan Key Laboratory of Vaccine Research & Developent on Severe Infection Disease, Kunming 650118, China;
3 Yunnan Engineering Research of Vaccine Research and Development on Severe Infection Disease, Kunming 650118, China |
引用本文:
冯雪军, 龙琼, 唐增华, 黄惟巍, 刘存宝, 杨旭, 孙文佳, 白红妹, 马雁冰. 重组小鼠白细胞介素-33的原核表达制备及其粘膜免疫佐剂活性[J]. 中国生物工程杂志, 2017, 37(4): 26-32.
FENG Xue-jun, LONG Qiong, TANG Zeng-hua, HUANG Wei-wei, LIU Cun-bao, YANG Xu, SUN Wen-jia, BAI Hong-mei, MA Yan-bing. The Prokaryotic Expression of Recombinant Murine Interlukin (IL)-33 and Its Mucosal Immunization Affect as Adjuvant. China Biotechnology, 2017, 37(4): 26-32.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20170404
或
https://manu60.magtech.com.cn/biotech/CN/Y2017/V37/I4/26
|
[1] Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity, 2005,23(5):479-490.
[2] Moussion C, Ortega N, Girard J P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo:a novel ‘alarmin’? PLoS One, 2008,3(10):e3331.
[3] Komai-Koma M, Xu D, Li Y, et al. IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol, 2007,37(10):2779-2786.
[4] Su Z, Lin J, Lu F, et al. Potential autocrine regulation of interleukin-33/ST2 signaling of dendritic cells in allergic inflammation. Mucosal Immunology, 2013,6(5):921-930.
[5] Luzina I G, Pickering E M, Kopach P, et al. Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion. Journal of Immunology, 2012,189(1):403-410.
[6] Bourgeois E, Van L P, Samson M, et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol, 2009,39(4):1046-1055.
[7] Bonilla W V, Frohlich A, Senn K, et al. The alarmin interleukin-33 drives protective antiviral CD8+ T cell responses. Science, 2012,335(6071):984-989.
[8] Gao X, Wang X, Yang Q, et al. Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells. Journal of Immunology, 2015,194(1):438-445.
[9] Villarreal D O, Wise M C, Walters J N, et al. Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity. Cancer Res, 2014,74(6):1789-1800.
[10] Froidure A, Vandenplas O, D'Alpaos V, et al. Persistence of asthma following allergen avoidance is associated with proTh2 myeloid dendritic cell activation. Thorax, 2015,70(10):967-973.
[11]. Chu Xiaojie,Li Yang,Long Qiong,et al.Development of a HPV16 E7 CTLs peptides-based virus-like particle therapertic vaccine.China Biotechnology,2015,35(2):45-51.
[12] Gao K, Li X, Zhang L, et al. Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice. Cancer Letters, 2013,335(2):463-471.
[13] Bagarazzi M L, Yan J, Morrow M P, et al. Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses. Science Translational Medicine, 2012,4(155):138. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
